Alpex Acquisition

This amendment likely addresses SEC comments and is a step toward effectiveness of the IPO. The expanded China-related risk disclosures are crucial for investors evaluating the SPAC's ability to complete a business combination given its Chinese sponsor and management. The filing confirms trust mechanics unchanged.

This filing provides the complete terms of the SPAC IPO for investors, including redemption mechanics, trust value, deadline, sponsor conduct, and dilution. It is the foundational document for evaluating the investment opportunity.

What changed: A Schedule 13D beneficial ownership report and attached Exhibit 7.1 Joint Filing Agreement dated July 2, 2026, filed by Hugreat Ltd on behalf of itself and other undisclosed co-filers regarding Class A ordinary shares of Alpex Acquisition Corporation. The filing records a procedural joint-filing consent for the 13D submission concerning shares trading at a stated par value of US$0.0001 per share. It contains zero updates to the redemption calendar, trust accounting, extension voting, target acquisition progress, or sponsor behavior, as the exhibit consists solely of a signature page authorizing joint electronic submission. Why it matters: Investors monitoring the issuer’s search-phase timeline will note that the submission establishes a compliant filing conduit for Hugreat Ltd but introduces no trigger events for redemptions or liquidity shifts. The document attributes the signing role exclusively to Ningdi Shi, identified as a Director, and provides no information on customer concentration, revenue streams, addressable market estimates, strategic pivots, intellectual property developments, commercial alliances, legal proceedings, or leadership rotations beyond the signatory’s title. Because the attachment excludes the principal 13D body, it withholds the actual percentage of beneficial ownership, purpose of acquisition, and planned transaction timing, rendering it procedurally routine rather than operationally consequential.

What changed: A Form 8-K current report and accompanying audited balance sheet (Exhibit 99.1) disclosing the consummation of an initial public offering and a concurrent private placement financing. On June 26, 2026, the Company closed its IPO of 11,500,000 units at $10.00 per unit, generating $115,000,000 in gross proceeds, which included the full exercise of a 1,500,000-unit over-allotment option. Substantially concurrently, the sponsor, Hugreat Ltd, purchased 187,500 private units for $10.00 per unit, generating $1,875,000. The Company deposited exactly $115,000,000 into a trust account maintained by Equiniti Trust Company, LLC. The June 26, 2026 balance sheet shows $115,000,000 in trust cash and $898,682 in operating cash. Related-party liabilities include a $219,028 promissory note and a $805,000 deferred underwriting commission. The filing activates a 12-month business combination period from the June 24, 2026 registration statement effectiveness, establishing a firm deadline near June 2027. Why it matters: This filing completes the SPAC's capital formation and locks in the acquisition clock, meaning public shareholders now monitor the timeline toward redemption or liquidation options without interim deal announcements. The Company explicitly states it has 'not selected any specific Business Combination target' and has not engaged in 'substantive discussions' regarding an initial combination. Management outlines a strategy targeting the 'broader technology sector — specifically artificial intelligence, interactive gaming, consumer internet, and digital commerce.' Personnel details include Chief Executive Officer Xiaolin Zheng signing the report, while the Company notes executive compensation is capped at $12,500 per month ($7,500 for the chief executive officer and $5,000 for the chief financial officer) through September 2026, with $64,167 already incurred. Underwriting compensation includes 230,000 representative shares assigned a fair value of $251,713, plus a 0.7% deferred cash commission. Sponsor conduct terms stipulate that Hugreat Ltd holds 2,875,000 founder shares purchased for $25,000, waives redemption rights on those founder shares upon a failed combination, and agrees via letter agreement to vote all founder and public shares in favor of an initial business combination.

What changed: Routine compliance exhibit: Joint Filing Agreement (Exhibit A) attached to a Schedule 13G beneficial ownership report for Alpex Acquisition Corp, dated July 2, 2026. The filing records a Rule 13d-1(k) joint filing arrangement among Harraden Circle Investments, LLC; Harraden Circle Investors GP, LP; Harraden Circle Investors GP, LLC; Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; Harraden Circle Concentrated, LP; and Frederick V. Fortmiller, Jr. It contains no data on share quantities, acquisition costs, redemption voting activity, trust account valuations, extension proposals, business combination targets, or sponsor conduct, so tracked mechanical parameters remain unchanged. Why it matters: Administrative coordination by the Harraden Circle group clarifies co-filer responsibility for the primary Schedule 13G, but without the underlying ownership table showing percentages or share counts, the exhibit cannot move the redemption deadline, adjust trust value, trigger extension mechanisms, signal deal progress, or reflect sponsor conduct shifts. The text makes zero claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, and attributes no operational statements to any executive or director.

What changed: SEC Form 4 – Insider Ownership Report. This regulatory filing discloses that Hugreat Ltd and Shi Ningdi, both identified as 10% owners, executed an open-market purchase of 187,500 shares on 2026-06-26, leaving each with 187,500 shares held afterward. This transaction does not alter any SPAC operational mechanics: it contains no amendments to the redemption calendar, no adjustments to trust valuation protocols, no proposals for a business combination extension, no announcement of a target acquisition, and no commentary on sponsor conduct or corporate governance. Why it matters: At the time of filing on 2026-07-02, the submission contained no material developments regarding customer contracts, revenue metrics, market positioning, strategic initiatives, technology platforms, partner alignments, pending litigation, or executive staffing changes. Attributed solely to the statutory reporting duties of the two 10% equity holders, the recorded acquisition of 187,500 shares represents standard secondary market activity and provides no actionable signal for investors monitoring trust preservation, redemption thresholds, or deal execution timelines.

What changed: A Joint Filing Agreement appended to a Schedule 13G, executed by Feis Equities LLC and Lawrence M. Feis on July 1, 2026, consenting to file their beneficial ownership statements jointly pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934. Feis Equities LLC and Lawrence M. Feis formally agreed to file their July 1, 2026 Schedule 13G on behalf of each other. The document records no alterations to Alpex Acquisition’s trust account administration, redemption procedures, extension voting timelines, target acquisition progress, or sponsor governance. No financial metrics, customer data, revenue figures, market sizing, technology roadmaps, partnership terms, litigation claims, or personnel changes were disclosed or committed to by the filers. Why it matters: As a standard procedural exhibit authored exclusively by Feis Equities LLC and Lawrence M. Feis, it satisfies co-reporting requirements under the Securities Exchange Act for shared Class A ordinary share holdings. It introduces zero new contractual terms, capital calls, or strategic directives that would affect investor distribution rights, trust value trajectory, or deal momentum. Because it is purely administrative and carries no operational or financial weight attributable to the signatories, it remains immaterial to investment decision-making.

What changed: This filing is a Form 8-K Current Report accompanied by Exhibit 99.1, a Press Release dated June 30, 2026, announcing that Alpex Acquisition Corporation has initiated the administrative process allowing shareholders to separate the Class A ordinary shares, warrants, and rights originally sold as bundled units. According to the press release and Item 8.01, holders of 11,500,000 units may now elect to split those units into underlying securities, with separate trading slated to commence on or about July 7, 2026. The document explicitly states that the redeemable warrants carry an exercise price of $11.50 per share and each whole right entitles the holder to acquire one-fourth of one Class A ordinary share. Brokers must contact transfer agent VStock Transfer LLC to execute the separation. The filing does not adjust the trust account balance, does not propose an extension of the business combination timeline, reports zero deal progress or target identification, and contains no commentary on sponsor conduct. Xiaolin Zheng is recorded as the signing Chief Executive Officer, and Ying Xu is listed as the Chief Financial Officer in the press release contact block. Why it matters: This announcement establishes fixed structural parameters for investors tracking redemption windows and capitalization mechanics ahead of the existing deadline. By decoupling the instruments into discrete trading symbols (ALPX, ALPXW, ALPXR) from the bundled unit ticker (ALPXU), the filing removes ambiguity around warrant payoffs at $11.50 and rights dilution at a one-fourth share ratio, enabling precise modeling of post-combination equity distribution. The submission contains no claims regarding customers, revenue, market size, proprietary technology, strategic partnerships, or active litigation. Regarding strategy, the company maintains through its official boilerplate that it is a blank check vehicle formed to pursue mergers, share exchanges, asset acquisitions, or recapitalizations, with efforts that 'will not be limited to a particular industry or geographic region.' D. Boral Capital LLC is identified by the filing as the sole book-running manager for the initial offering whose effective date was set by the SEC on June 24, 2026. The document does not disclose the per-share trust account value, leaving investors to rely on separate quarterly or annual reports for that metric.

What changed: An 8-K current report filed by Alpex Acquisition Corporation announcing and documenting the closing of its initial public offering, including the IPO pricing, full exercise of the underwriters' over-allotment option, the concurrent private placement of units to the sponsor, deposit of IPO proceeds into the trust account, adoption of amended governing documents, appointment of independent directors, and the underlying underwriting, warrant, rights, trust, registration rights, transfer, and indemnification agreements. Alpex completed its IPO of 11,500,000 units at $10.00 per unit, including full exercise of the over-allotment option, generating gross proceeds of $115,000,000. The sponsor purchased 187,500 private units for $1,875,000. The company issued 230,000 representative shares to the underwriter's representative. A total of $115,000,000, or $10.00 per public unit sold, was placed in the trust account. The units began trading on Nasdaq under ALPXU on June 25, 2026. Three independent directors were appointed and each received 20,000 ordinary shares from the sponsor at approximately $0.01 per share. The company also adopted amended and restated memorandum and articles of association and entered into the standard SPAC agreement suite. No business combination target had been identified as of the underwriting agreement, and no substantive target discussions had been initiated. Why it matters: This filing establishes the SPAC's operative mechanics for investors: approximately $10.00 per public unit is held in trust; the company must complete a business combination within 12 months from the June 26, 2026 IPO closing unless extended per its charter; public shareholders will have redemption rights in connection with a business combination or charter amendments; the sponsor, insiders, and representative shares have waived redemption/liquidation rights; warrants are exercisable at $11.50 per share; each right converts into one-fourth of a Class A share upon a business combination; and the company is still in the searching phase with no target identified. The IPO close also sets the clock for the trust-related deadline and defines the sponsor's 20% founder-share retention/forfeiture terms.

What changed: SEC Form 3 initial statement of beneficial ownership (insider ownership report). This filing identifies a routine ownership declaration by director Hua Joy Yi, who self-reports a position of 20,000 direct shares. Regarding tracked mechanics, the document registers zero alterations to the redemption deadline, trust value, extension schedule, or business combination pipeline; no sponsor conduct or capital structure adjustments are disclosed. Regarding other substance, the text contains no claims, projections, or disclosures concerning customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: For an investor monitoring redemption windows, trust distributions, extension votes, or sponsor behavior during a SEARCHING phase, this routine compliance exhibit exerts no influence on the SPAC’s lifecycle timeline or public shareholder rights. It merely catalogues an existing director holding without signaling shifts in deal status, governance posture, or financial expectations.

What changed: FORM 3 — Insider Ownership Report filed by director Geffner Xin Yue Jasmine regarding direct holdings in Alpex Acquisition Corp. The filing records a direct holding of 20,000 shares. It discloses no amendments to the SPAC’s charter, no changes to the redemption deadline (2027-06-25), no updates to the trust value ($10 per share), no extension requests, no target acquisition negotiations, and no sponsor conduct adjustments. Why it matters: As a routine compliance exhibit, this disclosure tracks officer/director equity positions for regulatory transparency. It contains zero forward-looking statements, revenue metrics, customer counts, partnership announcements, litigation references, or strategic pivots attributed to management or the board. Because it merely documents a reported purchase of 20,000 shares without crossing the 5% reporting threshold or altering governance terms, it leaves redemption calculus, trust distribution mechanics, and merger timelines entirely intact. The ownership record is attributed to director Geffner Xin Yue Jasmine as stated in filing [0001213900-26-072641], and no computational adjustments or external trust conventions have been applied to the disclosed $10 per share value or the 2026-06-26 filing date.

What changed: SEC Form 3 insider ownership report. Filed 2026-06-26 under file number 0001213900-26-072642, the document records that director Ma Yuanmei holds 20,000 direct shares of Alpex Acquisition Corp. It contains no updates to redemption calendars, trust share valuations, extension proposals, target deal progression, or sponsor operational conduct. Why it matters: This is a standard initial beneficial ownership filing that establishes a baseline for director equity exposure without triggering capital events or timeline adjustments. The 20,000-share position noted in the report confirms director participation in the SEARCHING phase but does not alter shareholder redemption windows, trust distribution mechanics, or the corporate deadline structure.